794P Efficacy and tolerability of neoadjuvant treatment with T-VEC in difficult to resect primary basal cell carcinoma: A phase II clinical trial (NeoBCC)
Ressler, J.M., Kusienicka, A., Silmbrod, R., Silly, T., Bachmayr, V., Plaschka, M., Shaw, L.E., Zila, N., Stepan, A., Tschandl, P., Tittes, J., Roka, F., Haslik, W., Koenig, F., Kunstfeld, R., Petzelbauer, P., Halbritter, F., Weninger, W., Farlik, M., Hoeller, C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland
Hoeller, C., Ressler, J.M., Karasek, M., Lopez, V Aedo, Koch, L., Kehrer, H., Koelblinger, P., Weihsengruber, F., Kofler, J., Richtig, E., Michielin, O.A., Hafner, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland
Hoeller, C., Ressler, J.M., Karasek, M., Lopez, V Aedo, Koch, L., Kehrer, H., Koelblinger, P., Weihsengruber, F., Kofler, J., Richtig, E., Michielin, O.A., Hafner, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article